Subject Predicate Object
rJEtvHGv
a
Resource
Government response
government response summary
Reducing deaths from lung disease is a key NHS priority. NHS England funds specialist services for pulmonary fibrosis and is developing a new long-term plan to improve respiratory care.
government response details
The Government has a mandate to NHS England for 2018-19 which holds the NHS to account for its performance across the measures in the NHS Outcomes Framework. One of the key priorities in this framework is to prevent deaths from respiratory diseases.The Government has also announced a new five-year funding settlement for the NHS, which will see an increase of £20.5 billion in real terms by 2023-24. NHS leaders are currently developing a long-term plan, to be published at the end of this year, which will underpin this settlement. No decisions have been made yet over the share of funds to be allocated to lung diseases, however NHS England has highlighted respiratory healthcare as one of its main priorities to be included in the plan.Pulmonary fibrosis (PF) and idiopathic pulmonary fibrosis (IPF) are incurable types of interstitial lung disease (ILD) for which there are few treatment options. NHS England publishes a service specification for ILDs to encourage clinicians to refer patients to their nearest ILD centre for the appropriate investigations and treatment. The National Institute for Health and Care Excellence (NICE) also publishes guidelines and quality standards for IPF to help healthcare professionals diagnose the condition and provide effective treatment. There are only two licenced disease-modifying drugs available for IPF – pirfenidone and nintedanib. Both of these drugs are approved by NICE and are prescribed by the ILD centres. Other types of treatment such as rehabilitation, nursing support, home oxygen, and palliative care, are set out in the ILD service specification to make clear the standards of care expected from NHS providers. NHS England also funds the Respiratory Futures programme hosted by the British Thoracic Society (BTS). This is a resource to support innovation and sharing of best practice on respiratory conditions. The BTS maintains a registry to collect and review national data on IPF to improve the diagnosis and care of people living with the disease. The ILD service specification from NHS England is available here: https://www.england.nhs.uk/wp-content/uploads/2018/08/Interstitial-lung-disease-service-adult.pdf Department of Health and Social Care
government response created at
2018-10-24T09:16:18.917000+00:00
government response updated at
2018-10-24T09:16:18.917000+00:00
government response has e-petition
wcmPmg90
wcmPmg90
e-petition has government response
rJEtvHGv